Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to email@example.com so that we can defer those challenges. Your health and safety are paramount to us.
Posted 16 May 2012 | By Alexander Gaffney, RAC
The US Food and Drug Administration's (FDA) Office of Criminal Investigations and the US Department of Justice (DOJ) have announced the indictment of William Zinnanti, the former President and Owner of Zinnanti Surgical Design, for selling devices to hospitals in violations of current Good Manufacturing Practices (cGMPs).
According to a 15 May statement released by DOJ, Zinnanti Surgical Design manufactured a non-sterile surgical device used primarily in hospital settings to cut and suture tissue used around the thoracic vertebrae.
"The Information alleges that the surgical pencils were adulterated because the methods, facilities, and controls Zinnanti used for the manufacture, packing, and storage of the Bayonet Electro-Surgical Pencil did not comport with current good manufacturing practice to ensure that the devices were safe and effective and in compliance with the Federal Food, Drug, and Cosmetic Act," wrote DOJ in a press release.
"According to the charges in the Information, Zinnanti acted with the intent to defraud and mislead the FDA with regard to the manufacturing procedures he had in place," continued DOJ. "After questions surrounding the sterility of the device came to light in 2006, a nationwide and international recall was instituted."
In FDA's 2007 warning letter to Zinnanti, FDA noted serious deficiencies in the company compliance with cGMP and quality system regulations, in addition to a host of other problems.
Zinnanti faces up to three years in jail and a $250,000 fine if convicted of the charges. In remarks to The Patriot News, Zinnanti's lawyer, Alan Caplan, said Zinnanti hopes to plead guilty to the charge so he can avoid jail time and continue practicing medicine at Stanford University.
FDA/DOJ - May 15, 2012: Former Hershey Resident Charged Federally with Adulteration of Medical Devices
Patriot-News - Former Hershey medical researcher charged in federal criminal case
FDA Warning Letter - Zinnanti Surgical Design, LLC 19-Sep-07
Tags: Indictment, Surgical, Zinnanti, Sterility, warning letter, Latest News, cGMP, medical device
Regulatory Focus newsletters
All the biggest regulatory news and happenings.